EMT Cancer Research Results

EMT, Epithelial-Mesenchymal Transition: Click to Expand ⟱
Source:
Type:
Biological process in which epithelial cells lose their cell polarity and cell-cell adhesion properties and gain mesenchymal traits, such as increased motility and invasiveness. This process is pivotal during embryogenesis and wound healing. Hh signaling pathway is able to regulate the EMT. Snail, E-cadherin and N-cadherin, key components of EMT; EMT-related factors, E-cadherin, N-cadherin, vimentin; The hallmark of EMT is the upregulation of N-cadherin followed by the downregulation of E-cadherin.
EMT is regulated by various signaling pathways, including TGF-β, Wnt, Notch, and Hedgehog pathways. Transcription factors such as Snail, Slug, Twist, and ZEB play critical roles in repressing epithelial markers (like E-cadherin) and promoting mesenchymal markers (like N-cadherin and vimentin).
EMT is associated with increased tumor aggressiveness, enhanced migratory and invasive capabilities, and resistance to apoptosis.


Scientific Papers found: Click to Expand⟱
2384- MET,    Integration of metabolomics and transcriptomics reveals metformin suppresses thyroid cancer progression via inhibiting glycolysis and restraining DNA replication
- in-vitro, Thyroid, BCPAP - in-vivo, NA, NA - in-vitro, Thyroid, TPC-1
Glycolysis↓, OXPHOS↑, tumCV↓, TumCI↓, TumCMig↓, EMT↓, Apoptosis↑, TumCCA↑, LDHA↓, PKM2↓, IDH1↑, TumCG↓,
2378- MET,    Metformin inhibits epithelial-mesenchymal transition of oral squamous cell carcinoma via the mTOR/HIF-1α/PKM2/STAT3 pathway
- in-vitro, SCC, CAL27 - in-vivo, NA, NA
TumCP↓, TumCMig↓, TumCI↓, EMT↓, mTOR↓, Hif1a↓, PKM2↓, STAT3↓, E-cadherin↑, Vim↓, Snail↓, STAT3↓,
2377- MET,    Metformin Inhibits TGF-β1-Induced Epithelial-to-Mesenchymal Transition via PKM2 Relative-mTOR/p70s6k Signaling Pathway in Cervical Carcinoma Cells
- in-vitro, Cerv, HeLa - in-vitro, Cerv, SiHa
EMT↓, P70S6K↓, mTOR↓, PKM2↓, Warburg↓, AMPK↑,
2376- MET,    Metformin Inhibits Epithelial-to-Mesenchymal Transition of Keloid Fibroblasts via the HIF-1α/PKM2 Signaling Pathway
- in-vitro, Nor, NA
*Hif1a↓, *EMT↓, *p‑P70S6K↓, *PKM2↓,
2386- MET,    Mechanisms of metformin inhibiting cancer invasion and migration
- Review, Var, NA
OS↑, AMPK↑, EMT↓, TGF-β↓, mTOR↓, P70S6K↓, PKM2↓, Hif1a↓, ChemoSen↑,
2371- MET,    The role of pyruvate kinase M2 in anticancer therapeutic treatments
- Review, Var, NA
ChemoSen↑, PKM2↓, Hif1a↓, EMT↓,
8483- MF,    Magnetic Fields in Cancer Therapy: Mechanistic Insights, Signaling Pathways, and Evidence from Clinical and In Vitro Studies
- Review, Var, NA
Apoptosis↑, TumCP↓, Ferroptosis↑, TumCMig↓, EMT↓, ROS↝, ChemoSen↑, RadioS↑, Telomerase↓, selectivity↑, ROS↑, DNAdam↑, Casp↑, Ca+2↑, MMP↓, lysoMP↑, lipid-P↑, NA↑, other↑, ChemoSen↑, P53↑,
9075- MGF,    Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β-catenin signaling pathway
- vitro+vivo, BC, MDA-MB-231
tumCV↓, TumMeta↓, MMP7↓, MMP9↓, EMT↓, β-catenin/ZEB1↓, TumVol↓, TumW↓, TumCP↓, Apoptosis↑, Vim↓, E-cadherin↑,
8662- MLT,    Melatonin inhibits bladder tumorigenesis by suppressing PPARγ/ENO1-mediated glycolysis
- vitro+vivo, Bladder, 5637 - in-vitro, CRC, T24/HTB-9 - in-vitro, HNSCC, UM-SCC-1
Glycolysis↓, ENO1↓, ROS↑, TumCP↓, TumMeta↓, TumCCA↑, Casp3↑, BIM↑, Bcl-2↓, γH2AX↑, EMT↓, N-cadherin↓, MMP9↓, Snail↓, Akt↓, eff↓, TumVol↓, PPARγ↓,
8683- MLT,    Intra-tumor ROS amplification by melatonin interferes in the apoptosis-autophagy-inflammation-EMT collusion in the breast tumor microenvironment
- in-vivo, BC, NA
ROS↑, SIRT1↑, IL6↓, STAT3↓, NF-kB↓, PI3K↓, Akt↓, mTOR↓, TumCP↓, tumCV↓, JNK↑, P53↑, Bax:Bcl2↑, cl‑Casp3↑, Apoptosis↑, eff∅, TumAuto↑, EMT↓, Half-Life↓, CompStab↓, BioAv↓, Dose↝, TumW↓, TumVol↓, Ki-67↓, PTEN↑,
8675- MLT,    Melatonin combined with antineoplastic drugs or natural products for cancer treatment: An update
- Review, Var, NA
ChemoSen↑, TumCP↓, TumCMig↓, CSCs↓, MDR1↓, chemoP?, IL1β↓, IL6↓, IL8↓, TNF-α↓, COX2/PTGS2↓, iNOS↓, Bcl-2↓, Mcl-1↓, IAP1↓, survivin↓, PCNA↓, Ki-67↓, CC(CDKs/cyclins)↓, TumCMig↓, TumCI↓, Fibronectin↓, Vim↓, N-cadherin↓, MMP2↓, MMP9↓, Synergy↑, Synergy↑, OCT4↓, Nanog↓, ERCC1↓, P-gp/ABCB1↓, EMT↓, Synergy↑, ChemoSen↑,
8615- MO,    Melissa officinalis Extract Induces Apoptosis and Inhibits Migration in Human Colorectal Cancer Cells
- in-vitro, CRC, HCT116 - in-vitro, CRC, HT-29 - in-vitro, CRC, SW-620
AntiCan↑, TumCP↓, TumCCA↑, Casp↑, TumCMig↓, EMT↓, other↑,
8906- MOR,    Morin, a avonoid from Moraceae, suppresses growth and invasion of the highly metastatic breast cancer cell line MDA-MB-231 partly through suppression of the Akt pathway
- vitro+vivo, BC, MDA-MB-231
EMT↓, TumCI↓, MMP9↓, ACADS/SCAD↓, p‑Akt↓, AntiTum↓, Dose↝,
8874- MOR,    The anticarcinogenic and anticancer effects of the dietary flavonoid, morin: Current status, challenges, and future perspectives
- Review, Var, NA
AntiCan↑, selectivity↑, *ROS↓, *Inflam↓, *p‑Akt↓, *NF-kB↓, ChemoSen↑, chemoPv↑, *toxicity↓, BioAv↑, BioAv↓, MRP1/ABCC1↝, BioAv↑, PCNA↓, hepatoP↑, NF-kB↓, TNF-α↓, IL6↓, PGE2↓, MMP2↓, MMP9↓, Apoptosis↑, TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, DR5↑, FasL↑, FADD↑, ROS↑, MMP↓, BAX↑, Bcl-xL↓, Casp9↑, Casp3↑, EMT↓, Akt↓, Hippo↑,
8864- MOR,    Morin, a flavonoid from Moraceae, suppresses growth and invasion of the highly metastatic breast cancer cell line MDA-MB‑231 partly through suppression of the Akt pathway
- vitro+vivo, BC, MDA-MB-231
*antiOx↑, *Inflam↓, *AntiCan↑, TumCA↓, TumCI↓, MMP9↓, N-cadherin↓, EMT↓, p‑Akt↓, Akt↓,
8885- MOR,    Anti-Inflammatory and Anti-Migratory Effects of Morin on Non-Small-Cell Lung Cancer Metastasis via Inhibition of NLRP3/MAPK Signaling Pathway
- in-vitro, Lung, A549 - in-vitro, Lung, H1299
IL1β↓, IL18↓, IL6↓, TumCMig↓, TumCI↓, MMP2↓, MMP9↓, uPAR↓, uPA↓, EMT↓, Fibronectin↓, N-cadherin↓, Vim↓, NLRP3↓, MAPK↓,
1141- Myr,    Myricetin: targeting signaling networks in cancer and its implication in chemotherapy
- Review, Var, NA
*PI3K↑, *Akt↑, p‑Akt↓, SIRT3↑, p‑ERK↓, p38↓, VEGF↓, MEK↓, MKK4↓, MMP9↓, Raf↓, F-actin↓, MMP2↓, COX2/PTGS2↓, BMP2↓, cycD1/CCND1↓, Bax:Bcl2↑, EMT↓, EGFR↓, TumAuto↑,
1129- NarG,    Naringenin Attenuated Prostate Cancer Invasion via Reversal of Epithelial-to-Mesenchymal Transition and Inhibited uPA Activity
- in-vitro, Pca, PC3
E-cadherin↓, Vim↓, Snail↓, Twist↓, EMT↓, uPA↓,
1799- NarG,    Naringenin as potent anticancer phytocompound in breast carcinoma: from mechanistic approach to nanoformulations based therapeutics
- Review, BC, NA
TumCCA↑, BioAv↑, Half-Life∅, TNF-α↓, Casp8↑, BAX↑, Bak↑, EGF↓, mTOR↓, PI3K↓, ERK↓, Akt↓, NF-kB↓, VEGF↓, angioG↓, antiOx↑, EMT↓, OS↑, MAPK↓, ChemoSen↑, MMP9↓, MMP2↓, ROS↑, ROS↑, GSH↓, Casp3↑, ROS↑,
5253- NCL,    Niclosamide: Beyond an antihelminthic drug
- Review, Var, NA
TumCP↓, Apoptosis↑, EMT↓, β-catenin/ZEB1↓, TumCG↓, toxicity↓, Wnt↓, LRP6↓, Synergy↑, DR5↑, mTORC1↓, pH↓, CSCs↓, IL6↓, JAK1↓, STAT3↓, ChemoSen↑, TumCG↓, tumCV↓, NOTCH↓, NF-kB↓, EGFR↓, ROS↑, RadioS↑, cFos↓, cJun↓, E2Fs↓, cMyc↓, Half-Life↓, BioAv↝,
6486- Nimb,    Nimbolide: promising agent for prevention and treatment of chronic diseases
- Review, Var, NA - Review, AD, NA
*other↝, *Inflam↓, AntiCan↑, *Bacteria↓, *AntiViral↑, *neuroP↑, *hepatoP↑, *ROS?, *NRF2↑, *HO-1↑, *TLR4↓, *NF-kB↓, *AChE↓, *Aβ↓, *GSK‐3β↓, *LDL↓, *DNAdam↓, *lipid-P↓, *antiOx↑, *SOD1↑, *GSH↑, *IL6↓, *IL1β↓, *STAT3↓, *GPx↑, *Catalase↑, *MDA↓, *AntiDiabetic↑, *HDL↓, *MCP1/CCL2↓, *VEGF↓, *MMP9↓, *GutMicro↑, TumCP↓, TumCCA↑, TumCMig↓, NF-kB↓, ROS↑, PI3K↓, Akt↓, mTOR↓, ERK↓, EMT↓, TumMeta↓, ChemoSen↑, eff↑, selectivity↑, CDK4↓, CDK6↓, Wnt↓, β-catenin/ZEB1↓, STAT3↓, MMP2↓, Sp1/3/4↓, AP-1↓, P21↑, *AntiArt↑, *IL23↓, *IL17↓, *IFN-γ↓, *HSP70/HSPA5↓,
4976- Nimb,    Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition
- vitro+vivo, PC, NA
ROS↑, Apoptosis↑, TumAuto↑, TumCP↓, TumCMig↓, TumCI↓, EMT↓, Dose↓, selectivity↑, Akt↓, eff↓, BAX↑, cl‑Casp3↑, cl‑PARP↑, Bcl-2↓,
4977- Nimb,    Nimbolide Inhibits SOD2 to Control Pancreatic Ductal Adenocarcinoma Growth and Metastasis
- vitro+vivo, PC, AsPC-1 - in-vitro, PC, PANC1
SOD2↑, TumCG↓, TumMeta↓, ROS↑, Apoptosis↑, PI3K↓, Akt↓, EMT↓, BAX↑, cl‑Casp3↑, cl‑Casp8↑, cl‑PARP↑, Bcl-2↓,
4646- OLEC,    Oleocanthal as a Multifunctional Anti-Cancer Agent: Mechanistic Insights, Advanced Delivery Strategies, and Synergies for Precision Oncology
- Review, Var, NA
BioAv↓, *Inflam↓, *antiOx↓, cMET↓, STAT3↓, TNF-α↓, COX2/PTGS2↓, EMT↓, angioG↓, *GutMicro↝, eff↑,
9049- PatchO,    Inhibitory effects of patchouli alcohol on hepatocellular carcinoma growth through accumulation of oxidative stress and inactivation of androgen receptor signaling
- vitro+vivo, HCC, HepG2 - in-vivo, Liver, HUH7
ROS?, MMP↓, DNAdam↑, TumCCA↑, Apoptosis↑, P53↑, P21↑, Fas↑, FasL↑, Casp8↑, BAX↑, Casp9↑, ChemoSen↑, AR↓, TumCP↓, selectivity↑, eff↓, Snail↓, Twist↓, ICAM-1↓, VCAM-1↓, MMP9↓, EMT↓, toxicity↓, chemoP↑,
3257- PBG,    The Potential Use of Propolis as a Primary or an Adjunctive Therapy in Respiratory Tract-Related Diseases and Disorders: A Systematic Scoping Review
- Review, Var, NA
CDK4↓, CDK6↓, pRB↓, ROS↓, TumCCA↑, P21↑, PI3K↓, Akt↓, EMT↓, E-cadherin↑, Vim↓, *COX2/PTGS2↓, *MPO↓, *MDA↓, *TNF-α↓, *IL6↓, *Catalase↑, *SOD↑, *AST↓, *ALAT↓, *IL1β↓, *IL10↓, *GPx↓, *TLR4↓, *Sepsis↓, *IFN-γ↑, *GSH↑, *NRF2↑, *α-SMA↓, *TGF-β↓, *IL5↓, *IL6↓, *IL8↓, *PGE2↓, *NF-kB↓, *MMP9↓,
1673- PBG,    An Insight into Anticancer Effect of Propolis and Its Constituents: A Review of Molecular Mechanisms
- Review, Var, NA
TumCP↓, Apoptosis↑, TumCCA↑, MALAT1↓, P53↑, RadioS↑, OS↑, ROS↑, NF-kB↓, p65↑, MMP↓, ROS↑, MMP9↓, β-catenin/ZEB1↓, Vim↓, E-cadherin↓, VEGF↓, EMT↓,
4922- PEITC,    Phenethyl Isothiocyanate: A comprehensive review of anti-cancer mechanisms
- Review, Var, NA
Risk↓, AntiCan↑, TumCP↓, TumMeta↓, ChemoSen↑, *BioAv↑, *other↝, *Dose↝, Dose↓, *BioAv↑, *Dose↝, *Half-Life↝, *toxicity↝, GSH↓, ROS↑, CYP1A1↑, CYP1A2↑, P450↓, CYP2E1↑, CYP3A4↓, CYP2A3/CYP2A6↓, *ROS↓, *GPx1↑, *SOD1↑, *SOD2↑, Akt↓, EGFR↓, HER2/EBBR2↓, P53↑, Telomerase↓, selectivity↑, MMP↓, Cyt‑c↑, Apoptosis↑, DR4↑, Fas↑, XIAP↓, survivin↓, TumAuto↑, Hif1a↓, angioG↓, MMPs↓, ERK↓, NF-kB↓, EMT↓, TumCI↓, TumCMig↓, Glycolysis↓, ATP↓, selectivity↑, *antiOx↑, Dose↝, other↝, OCR↓, GSH↓, ITGB1↓, ITGB6↓, ChemoSen↑,
4926- PEITC,    PEITC inhibits the invasion and migration of colorectal cancer cells by blocking TGF-β-induced EMT
- in-vitro, CRC, SW48
TumCI↓, TumCMig↓, EMT↓, Smad1↓, AntiCan↑, Snail↓, Slug↓, Zeb1↓, ZEB2↓, TGF-β1↓, Synergy↑, E-cadherin↑, N-cadherin↓, Vim↓,
9029- Phyco,    Advances about the study of phycocyanin in the treatment of breast cancer: A review
- Review, BC, NA
*antiOx↓, *Inflam↓, AntiTum↑, Apoptosis↑, ROS↑, mtDam?, TumCCA↑, TumCP↓, Tumccf↓, *toxicity↓, TumCG↓, EMT↓, COX2/PTGS2↓,
9012- Phyco,    Phycocyanin from Arthrospira platensis as Potential Anti-Cancer Drug: Review of In Vitro and In Vivo Studies
- Review, Var, NA
*Ingr↝, *antiOx↑, *Inflam↓, Imm↑, AntiCan↑, *toxicity↓, *Dose↝, *GutMicro↑, *IBI↑, Apoptosis↑, TumCCA↑, DNArepair↓, ROS↑, Cyt‑c↑, BAX↑, cl‑PARP1↑, CellShr↑, TumCMig↓, COX2/PTGS2↓, E-cadherin↑, MMP2↓, MMP9↓, HIF-1↓, angioG↓, MCP1/CCL2↓, MIP-1β↑, Ca+2↑, Cal9↑, Wnt↓, β-catenin/ZEB1↓, PPARα↑, PPARγ↑, eff↝, Half-Life↓, Synergy↑, ChemoSen↑, chemoP↑, EMT↓, N-cadherin↓, E-cadherin↑, TumCMig↓, TumCI↓, selectivity↑,
9011- Phyco,    Phycocyanin: A Potential Drug for Cancer Treatment
- Review, Var, NA
*antiOx↑, *Inflam↓, *AntiCan↑, *Imm↑, *RenoP↑, *hepatoP↑, Synergy↑, EMT↓, TumCCA↑, P21↑, cycE/CCNE↓, CDK2↓, Cyt‑c↑, Casp↑, cl‑PARP1↑, Bax:Bcl2↑, MMP↓, ROS↑, CD59↑, Fas?, IL1β↓, IL2↓, IFN-γ↓, TNF-α↓, JAK3↓, STAT3↓, IL4↑, COX2/PTGS2↓, PGE2↓, MMP9↓, MMP2↓, MMP9↓, TIMP2↓, Vim↓, COL1↓, E-cadherin↑, MDR1↓, AP-1↓, ChemoSen↑, chemoP↑, RadioS↑, TumAuto↑,
5211- PI,    Piperine inhibits colorectal cancer migration and invasion by regulating STAT3/Snail-mediated epithelial-mesenchymal transition
- in-vitro, CRC, NA
TumCMig↓, TumCI↓, EMT↓, Snail↓, STAT3↓,
1131- PI,    Piperlongumine‑loaded nanoparticles inhibit the growth, migration and invasion and epithelial‑to‑mesenchymal transition of triple‑negative breast cancer cells
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, BT549
TumCG↓, tumCV↓, TumCMig↓, TumCI↓, MMP2↓, Slug↓, N-cadherin↓, β-catenin/ZEB1↓, SMAD3↓, E-cadherin↑, EMT↓,
1059- PI,    Piperine Inhibits TGF-β Signaling Pathways and Disrupts EMT-Related Events in Human Lung Adenocarcinoma Cells
- in-vitro, Lung, A549 - in-vitro, BC, MDA-MB-231 - in-vitro, Liver, HepG2
EMT↓, p‑ERK↓, p‑SMAD2↓,
1258- PI,    Piperlongumine Alleviates Mouse Colitis and Colitis-Associated Colorectal Cancer
- in-vivo, CRC, NA
COX2/PTGS2↓, IL6↓, EMT↓, β-catenin/ZEB1↓, Snail↓, Symptoms∅,
1257- PI,    Piperlongumine attenuates bile duct ligation-induced liver fibrosis in mice via inhibition of TGF-β1/Smad and EMT pathways
- ex-vivo, LiverDam, NA
*Fibronectin↓, *α-SMA↓, *COL1↓, *COL3A1↓, *TGF-β↓, *EMT↓, *MMP2↓, *α-SMA↓, *Smad7↑, *E-cadherin↑, *Vim↓, *hepatoP↑, *antiOx↑, *GSH↑, *ROS↓,
1256- PI,    Hypoxia potentiates the cytotoxic effect of piperlongumine in pheochromocytoma models
- in-vitro, adrenal, PHEO - in-vivo, NA, NA
Apoptosis↑, ROS↑, TumCMig↓, TumCI↓, EMT↓, angioG↓, Necroptosis↑, MAPK↑, ERK↑,
2973- PL,    The Natural Alkaloid Piperlongumine Inhibits Metastatic Activity and Epithelial-to-Mesenchymal Transition of Triple-Negative Mammary Carcinoma Cells
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, 4T1
MMP2↓, MMP9↓, IL6↓, E-cadherin↑, ROS↑, EMT↓, Zeb1↓, Slug↓, TumMeta↓, selectivity↑, MMP2↓, GSH↓,
2948- PL,    The promising potential of piperlongumine as an emerging therapeutics for cancer
- Review, Var, NA
tumCV↓, TumCP↓, TumCI↓, angioG↓, EMT↓, TumMeta↓, *hepatoP↑, *lipid-P↓, *GSH↑, cardioP↑, CycB/CCNB1↓, cycD1/CCND1↓, CDK2↓, CDK1↓, CDK4↓, CDK6↓, PCNA↓, Akt↓, mTOR↓, Glycolysis↓, NF-kB↓, IKKα↓, JAK1↓, JAK2↓, STAT3↓, ERK↓, cFos↓, Slug↓, E-cadherin↑, TOP2↓, P53↑, P21↑, Bcl-2↓, BAX↑, Casp3↑, Casp7↑, Casp8↑, p‑HER2/EBBR2↓, HO-1↑, NRF2↑, BIM↑, p‑FOXO3↓, Sp1/3/4↓, cMyc↓, EGFR↓, survivin↓, cMET↓, NQO1↑, SOD2↑, TrxR↓, MDM2↓, p‑eIF2α↑, ATF4↑, CHOP/DDIT3↑, MDA↑, Ki-67↓, MMP9↓, Twist↓, SOX2↓, Nanog↓, OCT4↓, N-cadherin↓, Vim↓, Snail↓, TumW↓, TumCG↓, HK2↓, RB1↓, IL6↓, IL8↓, SOD1↑, RadioS↑, ChemoSen↑, toxicity↓, Sp1/3/4↓, GSH↓, SOD↑,
2952- PL,    Piperlongumine suppresses bladder cancer invasion via inhibiting epithelial mesenchymal transition and F-actin reorganization
- in-vitro, Bladder, T24/HTB-9 - in-vivo, Bladder, NA
TumCP↓, TumCCA↑, TumCMig↓, TumCI↓, ROS↑, Slug↓, β-catenin/ZEB1↓, Zeb1↓, N-cadherin↓, F-actin↓, GSH↓, EMT↓, CLDN1↓, ZO-1↓,
5163- PLB,    Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-mediated signaling pathway in human tongue squamous cell carcinoma cells
- in-vitro, SCC, SCC25
TumCP↓, NRF2↓, TumCCA↑, EMT↓, CSCs↓, eff↓, ROS↑, CycB/CCNB1↓, CDK1↓, CDK2↓, CDC25↓, Vim↓, OCT4↓, SOX2↓, Nanog↓, BMI1↓, NQO1↓, GSTA1↓, HSP90↓, toxicity↓,
4968- PSO,    Psoralidin: emerging biological activities of therapeutic benefits and its potential utility in cervical cancer
- in-vitro, Cerv, NA
*Inflam↓, *antiOx↑, *neuroP↑, *AntiDiabetic↑, *Bacteria↓, AntiTum↑, CSCs↓, ROS↑, TumAuto↑, Apoptosis↑, ChemoSen↑, RadioS↑, BioAv↓, *cardioP↑, *ROS↓, *LDH↓, TumCP↓, TRAIL⇅, TumCMig↓, EMT↓, NF-kB↓, P53↑, Casp3↑, NOTCH↓, CSCs↓, angioG↓, VEGF↓, Ki-67↓, CD31/PECAM-1↓, TRAILR↑, MMP↓, BioAv↓, BioAv↑,
1236- PTS,    Pterostilbene inhibits the metastasis of TNBC via suppression of β-catenin-mediated epithelial to mesenchymal transition and stemness
- in-vitro, BC, MCF7 - in-vitro, BC, MDA-MB-231 - in-vitro, BC, MDA-MB-468
TumMeta↓, EMT↓, E-cadherin↑, Zeb1↓, Snail↓, β-catenin/ZEB1↓, CD44↓, MMPs↓, CSCs↓,
4693- PTS,    Pterostilbene in the treatment of inflammatory and oncological diseases
- Review, Var, NA
BioAv↑, *Inflam↓, *antiOx↑, AntiTum↑, BBB↑, Half-Life↝, *ROS↓, *NRF2↑, *NQO1↑, *HO-1↑, PTEN↑, miR-19b↓, TumCCA↑, ER Stress↑, PERK↑, ATF4↑, CHOP/DDIT3↑, Ca+2↝, EMT↓, NF-kB↓, Twist↓, Vim↓, E-cadherin↑, ChemoSen↑, toxicity∅, toxicity↝,
4701- PTS,  RES,    Targeting cancer stem cells and signaling pathways by resveratrol and pterostilbene
- Review, Var, NA
CSCs↓, E-cadherin↑, NF-kB↓, EMT↓, GRP78/BiP↓, CD133↓, COX2/PTGS2↓, β-catenin/ZEB1↓, NOTCH↓,
4699- PTS,    Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, HS587T - in-vivo, BC, MDA-MB-231
TumCMig↓, TumCI↓, E-cadherin↑, Snail↓, Slug↓, Vim↓, Zeb1↑, miR-205↑, Src↓, TumCG↓, FAK↓, EMT↓,
3368- QC,    The potential anti-cancer effects of quercetin on blood, prostate and lung cancers: An update
- Review, Var, NA
*Inflam↓, *antiOx↑, *AntiCan↑, Casp3↓, p‑Akt↓, p‑mTOR↓, p‑ERK↓, β-catenin/ZEB1↓, Hif1a↓, AntiAg↓, VEGFR2/KDR/Flk1↓, EMT↓, EGFR↓, MMP2↓, MMP↓, TumMeta↓, MMPs↓, Akt↓, Snail↓, N-cadherin↓, Vim↓, E-cadherin↑, STAT3↓, TGF-β↓, ROS↓, P53↑, BAX↑, PKCδ↓, PI3K↓, COX2/PTGS2↓, cFLIP↓, cycD1/CCND1↓, cMyc↓, IL6↓, IL10↓, Cyt‑c↑, TumCCA↑, DNMTs↓, HDAC↓, ac‑H3↑, ac‑H4↑, Diablo↑, Casp3↑, Casp9↑, PARP1↑, Synergy↑, PTEN↑, VEGF↓, NO↓, iNOS↓, ChemoSen↑, Synergy↑, Synergy↑, Synergy↑, uPA↓, CXCR4↓, CXCL12↓, CLDN2↓, CDK6↓, MMP9↓, TSP-1↑, Ki-67↓, PCNA↓, ROS↑, ER Stress↑,
3369- QC,    Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects
- Review, Pca, NA
FAK↓, TumCCA↑, p‑pRB↓, CDK2↑, CycB/CCNB1↓, CDK1↓, EMT↓, PI3K↓, MAPK↓, Wnt↓, ROS↑, miR-21↑, Akt↓, NF-kB↓, FasL↑, Bak↑, BAX↑, Bcl-2↓, Casp3↓, Casp9↑, P53↑, p38↑, MAPK↑, Cyt‑c↑, PARP↓, CHOP/DDIT3↑, ROS↓, LDH↑, GRP78/BiP↑, ERK↑, MDA↓, SOD↑, GSH↑, NRF2↑, VEGF↓, PDGF↓, EGF↓, FGF↓, TNF-α↓, TGF-β↓, VEGFR2/KDR/Flk1↓, EGFR↓, FGFR1↓, mTOR↓, cMyc↓, MMPs↓, LC3B-II↑, Beclin-1/ATG6↑, IL1β↓, CRP↓, IL10↓, COX2/PTGS2↓, IL6↓, TLR4↓, Shh↓, HER2/EBBR2↓, NOTCH↓, DR5↑, HSP70/HSPA5↓, CSCs↓, angioG↓, MMP2↓, MMP9↓, IGFBP3↑, uPA↓, uPAR↓, RAS↓, Raf↓, TSP-1↑,
3374- QC,    Therapeutic effects of quercetin in oral cancer therapy: a systematic review of preclinical evidence focused on oxidative damage, apoptosis and anti-metastasis
- Review, Oral, NA - Review, AD, NA
α-SMA↓, α-SMA↑, TumCP↓, tumCV↓, TumVol↓, TumCI↓, TumMeta↓, TumCMig↓, ROS↑, Apoptosis↑, BioAv↓, *neuroP↑, *antiOx↑, *Inflam↓, *Aβ↓, *cardioP↑, MMP↓, Cyt‑c↑, MMP2↓, MMP9↓, EMT↓, MMPs↓, Twist↓, Slug↓, Ca+2↑, AIF↑, Endon↑, P-gp/ABCB1↓, LDH↑, HK2↓, PKA↓, Glycolysis↓, GlucoseCon↓, lactateProd↓, GRP78/BiP↑, Casp12↑, CHOP/DDIT3↑,

Showing Research Papers: 251 to 300 of 381
Prev Page 6 of 8 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 381

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 2,   NA?, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 2,   antiOx↑, 7,   Catalase↓, 7,   Catalase↑, 1,   ENOX2↓, 1,   Fenton↑, 1,   frataxin↑, 1,   GPx↓, 3,   GPx1↓, 1,   GPx4↓, 8,   GPx4↝, 1,   GSH↓, 21,   GSH↑, 4,   GSH/GSSG↓, 1,   GSR↓, 2,   GSR↑, 1,   ox-GSSG↑, 1,   GSTs↓, 2,   GSTs↑, 1,   H2O2↑, 1,   HO-1↓, 8,   HO-1↑, 14,   Iron↑, 3,   c-Iron↑, 1,   Keap1↑, 1,   lipid-P↓, 2,   lipid-P↑, 8,   MDA↓, 2,   MDA↑, 4,   NQO1?, 1,   NQO1↓, 3,   NQO1↑, 5,   NRF2↓, 20,   NRF2↑, 16,   NRF2↝, 1,   PYCR1↓, 1,   RNS↑, 1,   ROS?, 2,   ROS↓, 21,   ROS↑, 148,   ROS⇅, 5,   ROS↝, 2,   i-ROS↓, 1,   mt-ROS↑, 2,   selenoP↑, 1,   SOD↓, 12,   SOD↑, 3,   SOD1↓, 3,   SOD1↑, 1,   SOD2↓, 4,   SOD2↑, 2,   Trx↓, 1,   Trx1↑, 1,   TrxR↓, 2,   TrxR1↓, 1,   VitC↓, 1,   VitE↓, 1,   xCT/SLC7A11↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 2,   IronCh↑, 1,   STEAP3↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

BCR-ABL↓, 1,   CDC2↓, 6,   CDC25↓, 7,   compI↓, 1,   compIII↓, 2,   compIV↓, 1,   compV↓, 1,   EGF↓, 6,   ETC↓, 3,   Insulin↓, 1,   mitResp↓, 4,   mitResp↑, 1,   Mortalin↓, 1,   mtDam?, 1,   mtDam↑, 16,   OCR↓, 4,   OXPHOS↓, 2,   OXPHOS↑, 2,   mt-OXPHOS↓, 1,   PDH↓, 1,   PDH↝, 1,   SDH↓, 1,   SIRT3↓, 1,   SIRT3↑, 4,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 1,   5LO↓, 2,   AApath↓, 1,   ACADS/SCAD↓, 1,   ACC↑, 1,   ACC-α↓, 1,   ACC1↓, 1,   ACLY↓, 2,   p‑ACLY↓, 1,   ACSL4↑, 1,   ALAT↓, 4,   AMPK↓, 1,   AMPK↑, 24,   AMPK↝, 1,   p‑AMPK↑, 1,   ATP↓, 15,   mt-ATP↓, 1,   CAIX/CA9↓, 2,   ECAR↓, 1,   ENO1↓, 1,   FABP4↑, 1,   FASN↓, 3,   GAPDH↓, 1,   glucoNG↓, 1,   glucose↓, 1,   glucose↝, 1,   GlucoseCon↓, 9,   GlutMet↓, 1,   Glycolysis↓, 28,   GSK‐3β↓, 10,   GSK‐3β↑, 2,   GSK‐3β↝, 1,   p‑GSK‐3β↓, 8,   HK1↓, 1,   HK2↓, 12,   HMG-CoA↓, 4,   IDH1↑, 1,   lactateProd↓, 9,   LDHA↓, 4,   LDL↓, 1,   lipoGen↓, 1,   NAD↓, 1,   NADPH↓, 4,   NADPH↑, 1,   O-Glc↓, 1,   PDK1 / PDPK1↓, 5,   p‑PDK1 / PDPK1↓, 2,   PDK3↑, 1,   PDKs↓, 1,   PFK↓, 1,   PFK1↓, 1,   PIP3↑, 1,   PKM2↓, 15,   PKM2↑, 1,   RARα↓, 1,   RARβ↑, 1,   RARγ↑, 1,   SIRT1↓, 10,   SIRT1↑, 4,   SIRT2↓, 1,   SREBP1/SREBF1↓, 3,   TCA↓, 1,   TumCM/A↓, 1,   Warburg↓, 5,  

Cell Death(tgid=5) ⓘ

AIF↑, 6,   APAF1↑, 3,   Apoptosis↓, 6,   Apoptosis↑, 132,   mt-Apoptosis↑, 1,   ASC↓, 1,   ASC↑, 1,   BAD↓, 1,   BAD↑, 3,   Bak↑, 7,   BAX↓, 1,   BAX↑, 63,   BAX↝, 1,   Bax:Bcl2↑, 17,   Bcl-2↓, 71,   Bcl-2↑, 1,   Bcl-xL↓, 18,   Bcl-xL↑, 1,   BID↑, 4,   p‑BID↓, 1,   BIM↓, 1,   BIM↑, 6,   BNIP3↑, 2,   BOK↑, 1,   Casp↑, 19,   Casp1↓, 3,   Casp10↑, 1,   Casp12↑, 1,   cl‑Casp12↑, 2,   cl‑Casp12↝, 1,   Casp3↓, 3,   Casp3↑, 75,   cl‑Casp3↑, 17,   Casp6↑, 1,   Casp7↑, 15,   Casp8↑, 17,   cl‑Casp8↑, 2,   Casp9↓, 1,   Casp9↑, 49,   cl‑Casp9↑, 5,   proCasp9↓, 1,   CellShr↑, 2,   cFLIP↓, 2,   Cyt‑c↓, 2,   Cyt‑c↑, 48,   mt-Cyt‑c↓, 1,   Diablo↑, 4,   DR5↑, 19,   Endon↑, 1,   FADD↑, 5,   Fas?, 1,   Fas↓, 1,   Fas↑, 16,   FasL↓, 1,   FasL↑, 5,   Ferroptosis↑, 13,   GSDMD↑, 1,   HEY1↓, 1,   IAP1↓, 5,   IAP2/BIRC3↓, 1,   IAP2/BIRC3↑, 1,   iNOS↓, 6,   Mcl-1?, 1,   Mcl-1↓, 15,   Mcl-1↑, 1,   p‑Mcl-1↓, 1,   MDM2↓, 7,   MDM2↑, 2,   p‑MDM2↓, 1,   MOMP↑, 1,   NAIP↓, 1,   Necroptosis↑, 1,   NOXA↑, 1,   p38↓, 5,   p38↑, 9,   p‑p38↓, 2,   p‑p38↑, 1,   PUMA↓, 1,   PUMA↑, 2,   Pyro↑, 2,   RIP3↑, 1,   survivin↓, 32,   TNFR 1↑, 2,   TRAIL↑, 1,   TRAIL⇅, 1,   TRAILR↑, 3,   TumCD↓, 1,   TumCD↑, 6,   TUNEL↑, 1,   XIAP↓, 19,   YAP/TEAD↓, 5,   YAP/TEAD↝, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 113,   Akt↑, 4,   Akt↝, 1,   p‑Akt↓, 31,   AKT1↓, 3,   Akt2↓, 1,   CIP2A↓, 1,   CK2↓, 3,   cMET↓, 4,   cSrc↓, 1,   DDIT4↑, 1,   EF-1α↓, 1,   EGFR↓, 31,   EGFR↑, 1,   p‑EGFR↓, 1,   ERK↓, 30,   ERK↑, 7,   ERK↝, 1,   p‑ERK↓, 10,   ERK5↑, 1,   FGFR1↓, 4,   FGFR2↓, 1,   FOXD3↑, 1,   HER2/EBBR2↓, 7,   p‑HER2/EBBR2↓, 1,   HGF/c-Met↓, 1,   Hippo↑, 1,   Hippo↝, 1,   IGF-1R↓, 1,   IKKα↓, 7,   IKKα↑, 1,   p‑IKKα↓, 1,   IκB↓, 1,   p‑IκB↓, 1,   JAK↓, 3,   p‑JAK↓, 1,   JAK1↓, 2,   JAK1↑, 1,   JAK2↓, 6,   p‑JAK2↓, 3,   JAK3↓, 1,   p‑JAK3↓, 1,   JNK↓, 5,   JNK↑, 12,   JNK↝, 1,   p‑JNK↓, 1,   p‑JNK↑, 1,   LIMK1↓, 1,   p‑MAP2K1/MEK1↓, 1,   MAPK↓, 31,   MAPK↑, 9,   MAPK↝, 1,   p‑MAPK↓, 1,   MARK4↓, 1,   MEK↓, 5,   MKK4↓, 1,   mTOR↓, 65,   mTOR↝, 1,   p‑mTOR↓, 6,   mTORC2↓, 2,   p70S6↓, 1,   P70S6K↓, 2,   P90RSK↓, 2,   PDGFR-BB↓, 1,   PDGFRA↓, 1,   PI3K↓, 97,   PI3K↝, 1,   p‑PI3K↓, 7,   PI3K/Akt↓, 4,   PI3k/Akt/mTOR↓, 1,   PKA↓, 1,   PKCδ↓, 5,   PTEN↓, 3,   PTEN↑, 20,   Raf↓, 4,   c-Raf↓, 1,   RAS↓, 4,   RET↓, 1,   RIP1↑, 1,   p‑S6K↓, 1,   SHP1↑, 1,   Sp1/3/4↓, 12,   Src↓, 3,   p‑Src↓, 1,   STAT↓, 2,   p‑STAT2↓, 1,   STAT3↓, 57,   STAT3↑, 1,   STAT3↝, 1,   p‑STAT3↓, 12,   p‑STAT3↑, 2,   STAT6↓, 1,   p‑STAT6↓, 1,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF3↑, 1,   ATF4↓, 1,   ATF4↑, 10,   p‑ATF4↝, 1,   CBP↓, 1,   cJun↓, 7,   cJun↑, 1,   cMyc↓, 30,   p‑cMyc↑, 1,   DNMT1↓, 9,   DNMT3A↓, 5,   DNMT3B↓, 1,   DNMTs↓, 2,   EZH2↓, 6,   FOXM1↓, 3,   FOXO1↓, 3,   FOXO3↓, 2,   FOXO3↑, 4,   p‑FOXO3↓, 1,   FOXO4↓, 2,   H3↓, 2,   H3↑, 2,   ac‑H3↑, 3,   H3K27ac↓, 1,   H4↓, 1,   H4↑, 1,   ac‑H4↑, 2,   HATs↓, 2,   HATs↑, 3,   HDAC↓, 15,   HDAC1↓, 3,   HDAC10↓, 1,   HDAC2↓, 3,   HDAC3↓, 4,   HDAC4↓, 2,   HES1↓, 3,   HOTAIR↓, 1,   KLF4↓, 1,   miR-107↑, 1,   miR-10a-5p↝, 1,   miR-133a-3p↑, 1,   miR-139-5p↑, 1,   miR-140↑, 1,   miR-141↑, 1,   miR-145↑, 1,   miR-155↓, 1,   miR-155↝, 1,   miR-19b↓, 1,   miR-200b↑, 1,   miR-200c↑, 2,   miR-203↑, 1,   miR-205↑, 1,   miR-21↓, 5,   miR-21↑, 1,   miR-218↑, 1,   miR-224↓, 1,   miR-25-5p↓, 1,   miR-27a-3p↓, 1,   miR-29b↓, 1,   miR-29b↑, 1,   miR-301a-3p↓, 1,   miR-339-5p↝, 1,   miR-340↓, 1,   miR-34a↓, 3,   miR-34a↑, 4,   miR-34a↝, 1,   miR-34b-5p↑, 1,   miR-384↑, 2,   miR-422a↑, 1,   MTA2↓, 1,   Myc↓, 2,   n-MYC↓, 1,   NDRG1↑, 1,   OCT4↓, 19,   other↓, 3,   other↑, 4,   other↝, 6,   PAX2↓, 1,   PhotoS↑, 1,   SOX2↓, 9,   SOX4↓, 4,   SOX9?, 1,   SOX9↓, 1,   TCF-4↓, 2,   TFE3↑, 1,   tumCV↓, 32,   ZBTB10↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↑, 16,   p‑CHOP/DDIT3↝, 1,   cl‑CHOP/DDIT3↑, 1,   eIF2α↓, 1,   eIF2α↑, 3,   p‑eIF2α↑, 4,   p‑eIF2α↝, 1,   ER Stress↑, 33,   GRP78/BiP↓, 2,   GRP78/BiP↑, 12,   HSF1↓, 1,   HSP27↓, 6,   HSP70/HSPA5↓, 5,   HSP70/HSPA5↑, 1,   HSP90↓, 11,   IRE1↑, 5,   PDI↑, 1,   PERK↑, 7,   p‑PERK↝, 1,   Proteasome↓, 1,   SERPINH1/HSP47↓, 1,   UPR↓, 1,   UPR↑, 4,   XBP-1↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG5↑, 2,   ATG7↑, 1,   Beclin-1/ATG6↓, 2,   Beclin-1/ATG6↑, 10,   CTSB↓, 2,   CTSD↓, 2,   LC3‑Ⅱ/LC3‑Ⅰ↓, 1,   LC3B-II↑, 2,   LC3II↓, 2,   LC3II↑, 10,   LC3s↓, 1,   lysoMP↑, 1,   p62↓, 3,   p62↑, 2,   SESN2↑, 1,   TumAuto↑, 31,  

DNA Damage & Repair(tgid=10) ⓘ

ATM↑, 2,   BRCA1↑, 1,   BRCA1↝, 1,   p‑BRCA1↑, 1,   DFF45↓, 1,   DFF45↑, 2,   DNAdam↑, 35,   DNAdam⇅, 1,   DNArepair↓, 2,   ERCC1↓, 1,   ERCC3↑, 1,   m-FAM72A↓, 1,   hTERT/TERT↓, 10,   MGMT↓, 1,   p16↑, 2,   P53?, 1,   P53↓, 1,   P53↑, 56,   P53↝, 1,   p‑P53↑, 1,   ac‑P53↑, 1,   p53 Wildtype↑, 1,   p53 Wildtype∅, 1,   PARP↓, 1,   PARP↑, 15,   cl‑PARP↑, 27,   PARP1↑, 2,   cl‑PARP1↑, 2,   PCNA↓, 21,   PCNA↑, 1,   POLD1↓, 1,   SIRT6↓, 1,   Telomerase↓, 9,   TOP1?, 1,   TOP1↓, 6,   TOP2↓, 4,   TP53↑, 2,   TRF2↓, 1,   XRCC1↓, 1,   γH2AX↑, 7,   p‑γH2AX↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CC(CDKs/cyclins)↓, 1,   CDK1↓, 11,   CDK1↑, 1,   CDK2↓, 26,   CDK2↑, 3,   CDK4↓, 29,   CDK4↑, 1,   p‑CDK4↓, 1,   CDK6↓, 10,   CDK6↑, 1,   CDK8↓, 1,   CDKN1C/p57↑, 1,   CHK1↓, 1,   p‑CHK1↑, 1,   Chk2↓, 1,   p‑Chk2↑, 1,   ChrCon↑, 1,   cycA1/CCNA1↓, 3,   cycA1/CCNA1↑, 2,   CycB/CCNB1↓, 15,   CycB/CCNB1↑, 2,   cycD1/CCND1↓, 48,   cycD1/CCND1↑, 1,   p‑cycD1/CCND1↓, 1,   cycE/CCNE↓, 10,   E2Fs↓, 1,   Ki-67↓, 22,   MAD↓, 1,   P21?, 1,   P21↓, 3,   P21↑, 36,   p27/CDKN1B↓, 1,   p27/CDKN1B↑, 14,   pRB↓, 1,   p‑pRB↓, 2,   RB1↓, 1,   RB1↑, 2,   p‑RB1↓, 3,   TumCCA?, 1,   TumCCA↓, 4,   TumCCA↑, 115,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

ALDH↓, 7,   ALDH1A1↓, 7,   AXIN1↓, 1,   AXIN1↑, 1,   BMI1↓, 2,   BMP2↓, 1,   BMPs↑, 1,   CD133↓, 15,   CD133↑, 1,   CD24↓, 1,   CD34↓, 1,   CDX2↓, 1,   CEBPB↓, 1,   cFos↓, 7,   cFos↑, 1,   cMYB↓, 1,   CSCs↓, 71,   CSCsMark↓, 2,   Diff↓, 2,   Diff↑, 1,   EIF4E↓, 1,   FGF↓, 2,   FGF↑, 1,   Gli↓, 1,   Gli1↓, 13,   GREM1↓, 1,   HH↓, 16,   HH↝, 1,   IGF-1↓, 1,   IGF-2↓, 1,   IGFBP3↓, 1,   IGFBP3↑, 2,   Ki-67↓, 22,   Let-7↓, 1,   Let-7↑, 2,   LRP6↓, 3,   p‑LRP6↓, 1,   MSCmark↓, 1,   mTORC1↓, 4,   p‑mTORC1↓, 1,   Nanog↓, 18,   Nestin↓, 3,   NICD↓, 1,   NKD2↑, 1,   NOTCH↓, 19,   NOTCH↑, 2,   NOTCH1↓, 18,   NOTCH1↑, 3,   NOTCH1↝, 1,   NOTCH3↓, 3,   p300↓, 2,   Pirin↓, 1,   PTCH1↓, 4,   PTCH2↓, 1,   SFRP5↑, 1,   Shh↓, 13,   Smo↓, 6,   STAT1↓, 1,   p‑STAT1↓, 1,   Sufu↓, 1,   TAZ↓, 1,   TOPflash↓, 1,   TumCG?, 2,   TumCG↓, 66,   TumCG↑, 2,   TumCP?, 1,   TumCP↓, 120,   TumCP↑, 3,   tyrosinase↓, 1,   WDR72↓, 1,   Wnt↓, 47,   Wnt/(β-catenin)↓, 7,  

Migration(tgid=13) ⓘ

ACTA2↓, 1,   AEG1↓, 2,   AEG1↑, 1,   annexin II↓, 1,   AntiAg↓, 1,   AntiAg↑, 1,   AP-1↓, 8,   AP-1↝, 1,   AXL↓, 2,   CA↓, 1,   Ca+2↓, 1,   Ca+2↑, 22,   Ca+2↝, 2,   i-Ca+2↑, 1,   CAFs/TAFs↓, 2,   cal2↑, 1,   Cal9↑, 1,   Cdc42↓, 1,   Chl↑, 1,   Cofilin↓, 1,   COL1↓, 3,   COL1A1↓, 1,   COL3A1↓, 1,   CTNNB1↓, 1,   E-cadherin↓, 19,   E-cadherin↑, 133,   EM↑, 2,   EMT?, 1,   EMT↓, 364,   EMT↑, 7,   EMT↝, 2,   EpCAM↓, 1,   F-actin↓, 2,   F-actin↑, 1,   FAK↓, 16,   FAK↑, 1,   p‑FAK↓, 3,   fascin↓, 1,   Fibronectin↓, 13,   Galectin-9↓, 1,   GIT1↓, 1,   GLI2↓, 3,   IQGAP3↓, 1,   ITGA5↓, 2,   ITGA5↑, 1,   ITGB1↓, 7,   ITGB1↑, 1,   ITGB3↓, 1,   ITGB6↓, 1,   LAMA5↑, 1,   LAMs↓, 2,   LEF1↓, 4,   MALAT1↓, 4,   MET↓, 2,   MET↑, 1,   p‑MET↓, 2,   MMP-10↓, 2,   MMP1↓, 4,   MMP13↓, 3,   MMP16↓, 2,   MMP2↓, 103,   MMP2↝, 1,   MMP3↓, 6,   MMP7↓, 8,   MMP9↓, 109,   MMP9↑, 2,   MMP9↝, 1,   MMPs↓, 29,   MUC1↑, 1,   MUC4↓, 1,   N-cadherin↓, 92,   PAK1↓, 1,   p‑pax↓, 1,   PDGF↓, 5,   PIR↓, 1,   Rac1↓, 3,   RHBDD1↓, 1,   Rho↓, 6,   ROCK1↓, 9,   Slug?, 1,   Slug↓, 44,   Smad1↓, 4,   Smad1↝, 1,   SMAD2↓, 5,   p‑SMAD2↓, 10,   SMAD3↓, 7,   p‑SMAD3↓, 8,   SMAD4↓, 2,   Snail?, 2,   Snail↓, 81,   Snail↑, 2,   STAC2↓, 1,   TET1↓, 1,   TET1↑, 3,   TGF-β↓, 31,   TGF-β↑, 1,   TGF-β↝, 1,   TGF-β1↓, 3,   TIMP1↑, 6,   TIMP2↓, 3,   TIMP2↑, 2,   TRIB3↑, 2,   TSP-1↑, 4,   TumCA↓, 2,   TumCI↓, 134,   TumCI↑, 3,   TumCMig↓, 135,   TumCMig↑, 3,   TumMeta↓, 80,   TumMeta↑, 5,   Twist↓, 33,   Twist↑, 2,   Tyro3↓, 1,   uPA↓, 23,   uPAR↓, 2,   Vim?, 1,   Vim↓, 110,   Vim↑, 3,   Zeb1↓, 33,   Zeb1↑, 2,   ZEB2↓, 2,   ZEB2↑, 2,   α-SMA↓, 4,   α-SMA↑, 1,   α-tubulin↓, 1,   β-catenin/ZEB1↓, 69,   β-catenin/ZEB1↑, 2,   p‑β-catenin/ZEB1↓, 1,   cl‑β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 70,   angioG↑, 2,   CD31/PECAM-1↓, 3,   eNOS↓, 3,   HIF-1↓, 6,   Hif1a↓, 49,   Hif1a↑, 1,   Hif1a↝, 1,   NO↓, 1,   NO↑, 1,   NO↝, 1,   TXA2↓, 1,   VCAM-1↓, 2,   VEGF↓, 79,   VEGFR1↓, 2,   VEGFR2/KDR/Flk1↓, 14,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 1,   BBB↑, 4,   CLDN1↓, 6,   CLDN1↑, 1,   CLDN2↓, 1,   CLDN7↑, 1,   EPR↑, 1,   GLUT1↓, 6,   GLUT2↓, 1,   MMP↓, 65,   MMP↑, 1,   MPT↑, 4,   NHE1↓, 1,   OCLN↑, 1,   TRPV2↑, 1,   ZO-1↓, 1,   ZO-1↑, 6,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCR7↓, 1,   CD25+↓, 1,   CD4+↓, 2,   CD4+↑, 1,   CD44↓, 19,   CD59↑, 1,   CD8+↑, 4,   COX1↓, 2,   COX2/PTGS2↓, 52,   COX2/PTGS2↑, 1,   COX2/PTGS2↝, 1,   CXCL12↓, 4,   CXCL16↓, 1,   CXCR4↓, 10,   DR4↑, 3,   Eos↑, 1,   FOXP3↑, 1,   FoxP3+↓, 1,   HMGB1↓, 6,   ICAM-1↓, 4,   IFN-γ↓, 3,   IFN-γ↑, 2,   Igs↑, 1,   IL1↓, 4,   IL10↓, 4,   IL12↓, 1,   IL12↑, 1,   IL18↓, 2,   IL1β↓, 14,   IL2↓, 3,   IL2↑, 4,   IL4↓, 2,   IL4↑, 1,   IL6↓, 33,   IL6↑, 1,   IL8↓, 7,   Imm↑, 12,   Imm↝, 3,   Inflam↓, 22,   IRAK1↓, 1,   pol-M1↑, 1,   M2 MC↓, 2,   MCP1/CCL2↓, 6,   MCT1↓, 1,   MDSCs↓, 1,   MIP-1β↑, 1,   Neut↑, 1,   NF-kB↓, 104,   NF-kB↑, 4,   NF-kB↝, 1,   p‑NF-kB↓, 2,   p‑NF-kB↑, 2,   NK cell↑, 4,   NLRP3↓, 3,   p50↓, 1,   p65↓, 6,   p65↑, 1,   p‑p65↓, 5,   PD-1↓, 4,   PD-L1↓, 9,   PD-L2↓, 1,   PGE2↓, 20,   PSA↓, 4,   RAGE↓, 1,   SOCS-3↓, 1,   T-Cell↑, 1,   TCF↓, 5,   TCF7/TCF1↓, 2,   Th1 response↑, 2,   Th17↑, 1,   TILs↑, 1,   TIM-3↓, 1,   TLR4↓, 3,   TNF-α↓, 24,   TNF-α↑, 1,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 1,   TRADD↑, 1,  

Cellular Microenvironment(tgid=17) ⓘ

GGT/CD224↓, 1,   IM↓, 1,   pH↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

MAOA↓, 1,   PTN↓, 1,  

Protein Aggregation(tgid=19) ⓘ

PSEN1/PS1↓, 1,   XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AhR↓, 1,   AhR↓, 2,   AR↓, 13,   ER-α36↓, 1,   ER-α36↝, 1,   FGF21↓, 1,   PPARα↓, 1,   PPARα↑, 3,   PPARα↝, 1,   PPARγ↓, 3,   PPARγ↑, 4,  

Drug Metabolism & Resistance(tgid=21) ⓘ

AKR1B10↓, 1,   BioAv↓, 29,   BioAv↑, 29,   BioAv↝, 7,   ChemoSen↓, 1,   ChemoSen↑, 117,   ChemoSen⇅, 1,   CompStab↓, 2,   CompStab↑, 2,   CompStab↝, 1,   CYP1A1↓, 2,   CYP1A1↑, 2,   CYP1A2↑, 1,   CYP2A3/CYP2A6↓, 1,   CYP2E1↑, 1,   CYP3A4↓, 1,   Dose?, 2,   Dose↓, 3,   Dose↑, 4,   Dose↝, 22,   Dose∅, 6,   DrugR↓, 1,   eff↓, 16,   eff↑, 38,   eff↝, 7,   eff∅, 2,   GSTA1↓, 1,   GSTA1↑, 1,   Half-Life↓, 9,   Half-Life↑, 1,   Half-Life↝, 7,   Half-Life∅, 1,   MDR1↓, 9,   MRP1/ABCC1↓, 2,   MRP1/ABCC1↝, 1,   P-gp/ABCB1↓, 15,   P450↓, 4,   RadioS↑, 39,   selectivity?, 1,   selectivity↑, 41,   Synergy?, 1,   Synergy↑, 86,  

Clinical Biomarkers(tgid=22) ⓘ

AFP?, 1,   ALAT↓, 4,   ALB↑, 1,   ALP↓, 3,   AR↓, 13,   AST?, 1,   AST↓, 2,   BRCA1↑, 1,   BRCA1↝, 1,   p‑BRCA1↑, 1,   CA125↓, 1,   CEA↓, 1,   CRP↓, 2,   DBIL↓, 1,   E6↓, 3,   E7↓, 3,   EGFR↓, 31,   EGFR↑, 1,   p‑EGFR↓, 1,   EZH2↓, 6,   Ferritin↓, 2,   FOXM1↓, 3,   HER2/EBBR2↓, 7,   p‑HER2/EBBR2↓, 1,   hTERT/TERT↓, 10,   IBIL↓, 1,   IL6↓, 33,   IL6↑, 1,   IRes↓, 1,   LDH↓, 6,   LDH↑, 3,   Maspin↑, 1,   Myc↓, 2,   NOS2↓, 1,   NSE↓, 1,   PD-L1↓, 9,   Polyps↓, 1,   PSA↓, 4,   RAGE↓, 1,   TBIL↓, 1,   TG/TAG↓, 1,   TP53↑, 2,   TRIB3↑, 2,   Tumccf↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 26,   antiNeop↑, 1,   AntiTum↓, 2,   AntiTum↑, 16,   cachexia↓, 2,   cardioP↑, 6,   chemoP?, 1,   chemoP↑, 16,   chemoPv↑, 11,   ChemoSideEff↓, 4,   fatigue↓, 1,   hepatoP↑, 6,   neuroP↑, 5,   OS↑, 12,   Pain↓, 1,   PFS↑, 1,   Pin1↓, 2,   QoL↑, 3,   radioP↑, 3,   RenoP↑, 5,   Risk↓, 7,   Symptoms∅, 1,   toxicity?, 1,   toxicity↓, 9,   toxicity↑, 4,   toxicity↝, 7,   toxicity∅, 2,   TumVol↓, 17,   TumW↓, 7,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   AntiViral↑, 1,   Bacteria↓, 2,   GutMicro↑, 3,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 7,  
Total Targets: 996

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 4,   antiOx↑, 47,   Catalase↑, 20,   DPPH↓, 1,   GPx↓, 1,   GPx↑, 14,   GPx1↑, 1,   GPx4↑, 1,   GSH↑, 18,   GSR↑, 2,   GSTs↑, 8,   HDL↓, 1,   HDL↑, 1,   HO-1?, 1,   HO-1↑, 10,   i-Iron↓, 1,   Keap1↓, 1,   lipid-P↓, 13,   MDA↓, 14,   MDA↑, 1,   MPO↓, 3,   NQO1↑, 2,   NRF2↓, 1,   NRF2↑, 22,   Prx↑, 1,   RNS↓, 1,   ROS?, 1,   ROS↓, 59,   ROS↑, 1,   ROS⇅, 1,   SOD↓, 1,   SOD↑, 20,   SOD1↑, 2,   SOD2↑, 2,   TAC↑, 1,   TrxR↑, 1,   uricA↓, 1,   xCT/SLC7A11↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 1,   ACSL4↓, 1,   ALAT↓, 6,   AMPK↓, 1,   AMPK↑, 3,   ATP↓, 1,   DGAT1↓, 1,   FASN↓, 1,   glucose↓, 2,   GlucoseCon↑, 1,   GSK‐3β↓, 1,   LDHA↑, 1,   LDL↓, 2,   lipidLev↓, 1,   NAD↓, 1,   NAD↑, 1,   PKM2↓, 1,   PLA2↓, 1,   SIRT1↑, 4,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 1,   BAX↓, 3,   Bcl-2↓, 1,   Casp↓, 1,   Casp3?, 1,   Casp3↓, 5,   Casp9↓, 2,   Cyt‑c↓, 2,   Ferroptosis↓, 2,   iNOS↓, 4,   TUNEL↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 2,   Akt↑, 4,   Akt↝, 1,   p‑Akt↓, 1,   CREB↑, 1,   ERK↑, 1,   p‑ERK↓, 1,   JNK↓, 1,   JNK↑, 1,   MAPK↓, 1,   mTOR↓, 1,   mTOR↑, 2,   p‑mTOR↓, 1,   p‑P70S6K↓, 1,   PI3K↓, 1,   PI3K↑, 4,   PTEN↑, 1,   STAT3↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 3,   ATF4↓, 1,   p‑cMyc↑, 1,   HDAC↓, 1,   HDAC3↓, 1,   other↝, 2,   RUNX2↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 1,   ER Stress↓, 1,   HSP70/HSPA5↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 4,   LC3II↓, 1,   p62↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 2,   P53↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

GADD34↓, 1,   Ki-67↓, 1,   P21↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

p‑4E-BP1↓, 1,   BMP2↑, 1,   Ki-67↓, 1,   tyrosinase↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 2,   Ca+2↓, 1,   COL1↓, 3,   COL1↑, 1,   COL3A1↓, 1,   E-cadherin↑, 4,   EMT↓, 7,   EMT↑, 2,   Fibronectin↓, 1,   MMP13↓, 2,   MMP2↓, 1,   MMP9↓, 2,   Smad7↑, 2,   Snail↑, 1,   TGF-β↓, 3,   TGF-β1↓, 1,   TIMP1↓, 1,   TregCell↑, 1,   Twist↑, 1,   Vim↓, 4,   Vim↑, 1,   α-SMA↓, 6,   β-catenin/ZEB1↓, 1,   β-catenin/ZEB1↝, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↑, 1,   Hif1a↓, 2,   NO↓, 4,   NO↑, 1,   VEGF↓, 1,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 3,   GLUT2↑, 1,   GLUT3↑, 1,   GLUT4↑, 1,   IBI↑, 1,   MMP↑, 3,   TRPC1↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD40↓, 1,   COX2/PTGS2↓, 11,   HMGB1↓, 1,   ICAM-1↓, 1,   IFN-γ↓, 3,   IFN-γ↑, 1,   IL10↓, 4,   IL10↑, 1,   IL17↓, 3,   IL18↓, 1,   IL1β↓, 12,   IL2↓, 1,   IL2↑, 1,   IL23↓, 1,   IL4↓, 1,   IL4↑, 1,   IL5↓, 2,   IL6↓, 14,   IL8↓, 3,   Imm↓, 1,   Imm↑, 4,   Inflam?, 2,   Inflam↓, 49,   IP-10/CXCL-10↓, 1,   IRF3↓, 1,   LPS↓, 1,   MCP1/CCL2↓, 1,   MyD88↓, 1,   NeuroI↓, 1,   NF-kB↓, 17,   NK cell↑, 1,   NLRP3↓, 2,   PGE2↓, 8,   RAGE↓, 1,   SOCS-3↓, 1,   TLR2↓, 1,   TLR4↓, 5,   TNF-α↓, 18,  

Synaptic & Neurotransmission(tgid=18) ⓘ

AChE↓, 4,   BDNF↓, 1,   BDNF↑, 2,   GABA↑, 1,   MAOA↓, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 1,   Aβ↓, 9,   BACE/β-secretase↓, 2,   p‑tau↓, 2,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AHR↓, 1,   BNP↓, 1,   PPARα↝, 1,   p‑PPARγ↓, 1,   TSHR↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 26,   BioAv↑, 9,   BioAv↝, 4,   CYP2E1↓, 1,   Dose↑, 1,   Dose↝, 4,   eff↑, 6,   GSTA1↑, 1,   Half-Life↝, 7,   Half-Life∅, 1,   P450↓, 1,   Synergy↑, 3,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 6,   AST↓, 7,   BMD↑, 1,   BP↓, 1,   BUN↓, 1,   creat↓, 2,   CRP↓, 2,   IL6↓, 14,   LDH↓, 2,   RAGE↓, 1,   Urea↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 1,   antiAll↑, 6,   AntiArt↑, 2,   AntiCan↑, 6,   antiCG↑, 1,   AntiDiabetic↑, 10,   AntiTum↓, 1,   AntiTum↑, 2,   cardioP↑, 20,   chemoP↑, 2,   chemoPv↑, 5,   cognitive↑, 5,   diuretic↑, 1,   hepatoP↑, 23,   Learn↑, 1,   memory↑, 7,   motorD↑, 1,   Mucositis↓, 2,   neuroP↑, 36,   Obesity↓, 2,   PDE4↓, 1,   radioP↑, 2,   RenoP↑, 7,   Stroke↓, 2,   toxicity↓, 18,   toxicity↑, 1,   toxicity↝, 6,   toxicity∅, 2,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 3,   AntiFungal↑, 1,   AntiViral↑, 3,   Bacteria↓, 4,   GutMicro↑, 6,   GutMicro↝, 1,   Sepsis↓, 2,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 1,  
Total Targets: 258

Scientific Paper Hit Count for: EMT, Epithelial-Mesenchymal Transition
19 Curcumin
17 Resveratrol
16 Quercetin
13 Sulforaphane (mainly Broccoli)
13 Honokiol
13 Luteolin
9 Ashwagandha(Withaferin A)
9 EGCG (Epigallocatechin Gallate)
9 Fisetin
9 Thymoquinone
7 Kaempferol
6 Astragalus
6 Berberine
6 Matrine
6 Metformin
6 Piperine
6 Rosmarinic acid
5 Apigenin (mainly Parsley)
5 Betulinic acid
5 Chrysin
5 Emodin
5 Eugenol
5 Silymarin (Milk Thistle) silibinin
4 Alpha-Lipoic-Acid
4 Baicalein
4 Phenethyl isothiocyanate
4 Propolis -bee glue
4 Chlorogenic acid
4 Diindolylmethane
4 Inositol
4 Morin
4 Pterostilbene
4 Shikonin
3 Artemisinin
3 Atorvastatin
3 Benzyl isothiocyanate
3 5-fluorouracil
3 Cyclopamine
3 salinomycin
3 Genistein (soy isoflavone)
3 Ferulic acid
3 Fucoidan
3 Garcinol
3 HydroxyTyrosol
3 Isorhamnetin
3 Isothiocyanates
3 Lycopene
3 Magnolol
3 Melatonin
3 Nimbolide
3 Phycocyanin
3 Piperlongumine
3 Urolithin
2 Anethole/trans-Anethole
2 Cisplatin
2 Astaxanthin
2 Beta-Caryophyllene
2 brusatol
2 Capsaicin
2 Cannabidiol
2 Celecoxib
2 Centella asiatica / Gotu kola → asiaticoside
2 Crocetin
2 Radiotherapy/Radiation
2 Deguelin
2 Dandelion Root
2 Disulfiram
2 Ellagic acid
2 Sorafenib (brand name Nexavar)
2 Paclitaxel/Taxol
2 Ginkgetin
2 Grapeseed extract
2 phytic acid, Inositol hexakisphosphate
2 Isoliquiritigenin
2 isoflavones
2 isoorientin
2 isoquercitrin
2 Ivermectin
2 Juglone
2 Licorice
2 Lactoferrin/Talactoferrin
2 Naringin
2 Vitamin C (Ascorbic Acid)
2 Vitamin D3
2 VitK3,menadione
1 1,8-Cineole
1 Anthocyanins
1 Silver-NanoParticles
1 Allicin (mainly Garlic)
1 alpha Linolenic acid
1 DTS(dibenzyl trisulphide) from Anamu
1 Aspirin
1 Baicalin
1 Berbamine
1 Biochanin A
1 Allyl isothiocyanate
1 Brucea javanica
1 Boron
1 Caffeic acid
1 Carnosic acid
1 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
1 Cucurbitacin
1 Oxaliplatin
1 Dichloroacetate
1 Docosahexaenoic Acid
1 immunotherapy
1 Copper and Cu NanoParticles
1 Ginkgo biloba-EGb 761
1 Eurycomanone
1 Cinnamon
1 Evodiamine
1 Shilajit/Fulvic Acid
1 Gallic acid
1 Ginkgolide B
1 Proanthocyanidins
1 Hydrogen Gas
1 Chemotherapy
1 Hydroxycinnamic-acid
1 Hyperoside
1 Isovitexin
1 L-Theanine
1 methotrexate
1 Lutein
1 mebendazole
1 MCT, metronomic chemo
1 Magnetic Fields
1 Mangiferin
1 Lemon Balm/Melissa officinalis
1 Myricetin
1 Niclosamide (Niclocide)
1 Oleocanthal
1 Patchouli Oil (Pogostemon cablin)
1 Plumbagin
1 Psoralidin
1 Sanguinarine
1 α-Santalol/Sandalwood oil
1 Selenium
1 Selenate
1 Gemcitabine (Gemzar)
1 Spirulina(Arthrospira/Limnospira)
1 Selenite (Sodium)
1 statins
1 Citric Acid
1 Terpinen-4-ol / Tea Tree Oil
1 Thymol-Thymus vulgaris
1 Ursolic acid
1 Vitamin K2
1 Vitexin
1 Zinc
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:96  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page